Get startedLog in
    Picture of Aptose Biosciences logo

    APTOF — Aptose Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Aptose Biosciences Inc Says Initiates Dosing Of Cg-806 In Patients With Acute Myeloid Leukemia

    Picture of Aptose Biosciences logoAptose Biosciences
    19/10/2020 12:09
    Oct 19 (Reuters) - Aptose Biosciences Inc  APS.TO :
    * APTOSE BIOSCIENCES INC - INITIATES DOSING OF CG-806 IN
PATIENTS
WITH ACUTE MYELOID LEUKEMIA
    * APTOSE BIOSCIENCES INC - PHASE 1 A/B STUDY OF CG-806 IN
AML
INITIATES WITH STARTING DOSE OF 450MG

Source text: [https://bit.ly/3kcUiZt]
Further company coverage:  APS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Aptose Biosciences

    See all news